Portfolio

TechAviv's pre-seed founders fund backs and actively supports the world's elite Israeli founders.

Portfolio News

March 29, 2026

Bill Ackman invests in AI transitional care co Dimer Health

The company, which is building a new clinical infrastructure designed to close one of healthcare’s most costly and overlooked gaps, the 30 days following hospital discharge, has raised $20 million to date.

Read
January 11, 2026

Security Startup Torq Raises Cash at $1.2 Billion Valuation

The company builds an AI-native autonomous security operations platform that uses AI agents to automate repetitive and high-volume security tasks such as alert triage, allowing human analysts to focus on complex and high-risk threats. The funding highlights continued strong investor appetite for AI-driven cybersecurity solutions as enterprises struggle with growing attack surfaces and talent shortages in security operations.

Read
May 13, 2025

Somite AI Raises $47M Series A To Reinvent Cell Replacement Therapy

Startup Somite AI announced today that it has raised over $47 million in a Series A funding round, bringing its total funding to about $60 million. The round was led by Khosla Ventures, with participation from SciFi VC, the Chan Zuckerberg Initiative, Fusion Fund, Ajinomoto Group Ventures, Pitango HealthTech, TechAviv, Harpoon Ventures, and prominent angel investors such as Fidji Simo, the new CEO of Applications at OpenAI.

Read
August 21, 2024

Flytrex Achieves 100,000 Drone Deliveries, Pioneering Airborne Food Service In The US‌‌

Flytrex completes milestone deliveries, leveraging high-speed drones for rapid on-demand service in food delivery business. ‌

Read
April 10, 2024

This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Market

Five scientists walked into a lab late last year and decided to establish a startup combining their wide-ranging expertise, practical experience and breakthrough innovations. The goal of their startup, Somite.ai, is to improve the lives of millions of people by leveraging AI to produce human tissue for cell therapies. The market for the therapies for the diseases they aim to address is estimated at $250 billion.

Read